• OPEN AN ACCOUNT
Indian Indices
Nifty
25,517.05 -120.75
(-0.47%)
Sensex
83,606.46 -452.44
( -0.54%)
Bank Nifty
57,312.75 -131.15
( -0.23%)
Nifty IT
38,950.00 127.05
( 0.33%)
Global Indices
Nasdaq
43,834.06 426.21
(0.98%)
Dow Jones
6,192.89 30.87
(0.50%)
Hang Seng
40,353.62 202.83
(0.51%)
Nikkei 225
8,798.91 63.31
(0.72%)
Forex
USD-INR
85.73 -0.26
(-0.30%)
EUR-INR
100.32 0.36
(0.36%)
GBP-INR
117.66 0.46
(0.39%)
JPY-INR
0.59 0.00
(0.31%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

Biogen Pharmachem Industries standalone net profit rises 59.46% in the March 2025 quarter
May 24,2025
Net profit of Biogen Pharmachem Industries rose 59.46% to Rs 1.18 crore in the quarter ended March 2025 as against Rs 0.74 crore during the previous quarter ended March 2024. There were no Sales reported in the quarter ended March 2025 and during the previous quarter ended March 2024.

For the full year,net loss reported to Rs 0.29 crore in the year ended March 2025 as against net profit of Rs 1.93 crore during the previous year ended March 2024. There were no Sales reported in the year ended March 2025 and during the previous year ended March 2024.